CSP
MDT icon

Cary Street Partners’s Medtronic MDT Stock Holding History

Cary Street Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.84M Buy
112,940
+9,906
+10% +$799K 0.19% 124
2026
Q1 		$8.93M Buy
103,034
+1,945
+2% +$186K 0.22% 107
2025
Q4 		$9.71M Buy
101,089
+2,654
+3% +$258K 0.24% 101
2025
Q3 		$9.37M Buy
98,435
+494
+0.5% +$45.4K 0.24% 101
2025
Q2 		$8.54M Buy
97,941
+15,663
+19% +$1.33M 0.24% 100
2025
Q1 		$7.39M Buy
82,278
+34,992
+74% +$3.13M 0.23% 104
2024
Q4 		$3.78M Buy
+47,286
New +$4.09M 0.12% 165

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cary Street Partners's MDT Position: Q2 2026 in Review

Cary Street Partners increased its Medtronic (MDT) stake by 9.6% in Q2 2026, buying an estimated $799K and bringing the position to 112,940 shares worth $8.84M. The position accounts for 0.19% of the portfolio, ranked #124.

Cary Street Partners first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.71M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cary Street Partners held 112,940 shares of Medtronic worth $8.84M as of Q2 2026.
  • Cary Street Partners bought 9,906 Medtronic shares in Q2 2026, an estimated $799K.
  • Medtronic made up 0.19% of Cary Street Partners's portfolio in Q2 2026, its #124 holding.
  • Cary Street Partners first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Medtronic position peaked at $9.71M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.